Quest Diagnostics Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Quest Diagnostics (DGX) PT Lowered to $121 at Credit Suisse
October 24, 2018 8:47 AM EDTCredit Suisse analyst A.J. Rice lowered the price target on Quest Diagnostics (NYSE: DGX) to $121.00 (from $128.00) while maintaining an Outperform rating following results.
Rice said Long-term Tailwinds Still in Play, Despite a Short-term Speed Bump.
... MoreQuest Diagnostics (DGX) Reports In-Line Q3 EPS, Revenues Miss; Lowers FY18 EPS/Reveunes Outlook
October 23, 2018 6:48 AM EDTQuest Diagnostics (NYSE: DGX) reported Q3 EPS of $1.68, in-line with the analyst estimate of $1.68. Revenue for the quarter came in at $1.89 billion versus the consensus estimate of $1.95 billion.
"We grew revenues and continued to deliver strong earnings growth in the third quarter," said... More
